REQUEST A DEMO
Total
USD $0.00
Search more companies

Sang Lab - Klinicka Laborator s.r.o. (Czech Republic)

Main Activities: HMO Medical Centers
Full name: Sang Lab - Klinicka Laborator s.r.o. Profile Updated: November 15, 2019
Buy our report for this company USD 29.95 Most recent financial data: 2017 Available in: English & Czech Download a sample report

Sang Lab - Klinicka Laborator s.r.o. is based in Czech Republic. The head office is in Karlovy Vary. It operates in the HMO Medical Centers industry. It was first established on March 01, 1999. Sang Lab - Klinicka Laborator s.r.o. currently employs 50 - 99 (estimated) people. From the latest financial highlights, Sang Lab - Klinicka Laborator s.r.o. reported a net sales revenue drop of 5.48% in 2017. Its’ total assets recorded a growth of 14.43%. Sang Lab - Klinicka Laborator s.r.o.’s net profit margin increased by 19.27% in 2017.

Headquarters
Bezrucova 1098/10
Karlovy Vary; Karlovarsky; Postal Code: 36001

Contact Details: Purchase the Sang Lab - Klinicka Laborator s.r.o. report to view the information.

Basic Information
Total Employees:
Purchase the Sang Lab - Klinicka Laborator s.r.o. report to view the information.
Registered Capital:
Purchase the Sang Lab - Klinicka Laborator s.r.o. report to view the information.
Incorporation Date:
March 01, 1999
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Karlovarske Imunologicke Centrum s.r.o.
100%
Citylab spol. s.r.o.
50%
Company Performance
Financial values in the chart are available after Sang Lab - Klinicka Laborator s.r.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-5.48%
Total operating revenue
-5.86%
Operating profit (EBIT)
5.96%
EBITDA
7.82%
Net Profit (Loss) for the Period
48.63%
Total assets
14.43%
Total equity
-4.11%
Operating Profit Margin (ROS)
3.73%
Net Profit Margin
19.27%
Return on Equity (ROE)
20.61%
Quick Ratio
-0.45%
Cash Ratio
0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?